| Product Name / 产品名称 |
Structure
结构式 |
CAS NO. |
Indication
用途 |
3,4-二甲基苯肼盐酸盐
3,4-Dimethylphenylhydrazine hydrochloride |
 |
60481-51-8 |
伊曲波帕中间体
Eltrombopag |
2-(3,4-二甲基苯基)-1,2-二氢-5-甲基-3H-吡唑-3-酮
2-(3,4-Dimethylphenyl)-1,2-dihydro-5-methyl-3H-pyrazol-3-one |
 |
277299-70-4 |
伊曲波帕中间体
Eltrombopag |
3'-硝基-4'-苄氧基-2-溴苯乙酮
2-Bromo-4'-Benzyloxy-3'-nitroacetophenone |
 |
43229-01-2 |
福莫特罗中间体
Formoterol |
(R)-N-(2-(苄氧基)-5-(2-溴-1-羟基乙基)苯基)甲酰胺
(R)-N-(2-(Benzyloxy)-5-(2-bromo-1-hydroxyethyl)phenyl)formamide |
 |
201677-59-0 |
福莫特罗中间体
Formoterol |
1-(4-甲氧苯基)-2-苄胺基丙烷盐酸盐
1-(4-Methoxyphenyl)-2-benzylaminopropane hydrochloride |
 |
1049695-95-5 |
福莫特罗中间体
Formoterol |
盐酸氯卡色林半水
(1R)-8-Chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine hydrochloride hemihydrate |
 |
856681-05-5 |
氯卡色林
LORCASERIN |
(S)-1-(2,6-二氯-3-氟苯基)乙醇
(S)-1-(2,6-Dichloro-3-fluorophenyl)ethanol |
 |
877397-65-4 |
克卓替尼中间体
Crizotinib |
[5-溴-3-[(1R)-(2,6-二氯-3-氟苯基)乙氧基]吡啶-2-基]胺
(R)-5-bromo-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-2-amine |
 |
877399-00-3 |
克卓替尼中间体
Crizotinib |
4-[4-(4,4,5,5-四甲基-1,3,2-二氧杂环戊硼烷-2-基)-1H-吡唑-1-基]哌啶-1-甲酸叔丁酯
tert-Butyl 4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]piperidine-1-carboxylate |
 |
877399-74-1 |
克卓替尼中间体
Crizotinib |
2-氯-1,3-双(二甲基氨基)三亚甲六氟磷酸盐
2-Chloro-1,3-bis(dimentylamino)trimethinium hexafluorophosphate |
 |
249561-98-6 |
依托考昔中间体
Etoricoxib |
2-(4-甲磺酰基苯基)-1-(6-甲基吡啶-3-基)-乙酮
2-(4-MESYLPHENYL)-1-(6-METHYLPYRIDIN-3-YL)- ETHAN-1-ONE |
 |
221615-75-4 |
依托考昔中间体
Etoricoxib |
2,3-二甲基-6-氨基-2H-吲唑盐酸盐
2,3-dimethyl-2H-indazol-6-amine hydrochloride |
 |
635702-60-2 |
帕唑帕尼中间体
Pazopanib |
6-(4-甲基哌嗪-1-基)-4-(2-甲基苯基)烟酰胺
3-PYRIDINECARBOXAMIDE, 4-(2-METHYLPHENYL)-6-(4-METHYL-1-PIPERAZINYL)- |
 |
342417-01-0 |
萘妥皮坦中间体
Netupitant |
4-氯-7-甲苯磺酰基-7H-吡咯[2,3-D]嘧啶
4-CHLORO-7-TOSYL-7H-PYRROLO[2,3-D]PYRIMIDINE |
 |
479633-63-1 |
托法替尼中间体
Tofacitinib |
1-哌啶甲酸, 4-[1-(2-乙氧基乙基)-1H-苯并咪唑-2-基 酯
tert-butyl 4-(1-(2-ethoxyethyl)-1H-benzo[d]iMidazol-2-yl)piperidine-1-carboxylate |
 |
1181267-36-6 |
比拉斯汀中间体
Bilastine |
简体中文
English
日本語
한국어
